Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.041 USD | -10.28% | -17.17% | -33.33% |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Chart calendar Evelo Biosciences, Inc.
Upcoming events on Evelo Biosciences, Inc.
Past events on Evelo Biosciences, Inc.
2024-01-26 09:00 am | Extraordinary Shareholders Meeting |
2023-08-14 07:30 am | Q2 2023 Earnings Release |
2023-06-08 03:00 pm | Annual General Meeting |
2023-04-26 08:30 am | Business Update Call |
2023-03-16 08:30 am | Q4 2022 Earnings Call |
2023-03-16 07:00 am | Q4 2022 Earnings Release |
2023-03-07 12:50 pm | Cowen Health Care Conference - panel |
2023-02-01 08:30 am | Business Update Call |
2022-11-30 08:00 am | Science Symposium |
2022-11-15 02:25 am | Jefferies London Healthcare Conference |
2022-11-14 05:27 pm | Q3 2022 Earnings Release |
2022-09-13 12:20 pm | Morgan Stanley Global Healthcare Conference |
2022-08-11 07:30 am | Interim 2022 Earnings Call |
2022-08-11 06:00 am | Interim 2022 Earnings Release |
2022-06-09 03:00 pm | Annual General Meeting |
2022-05-12 06:00 am | Q1 2022 Earnings Release |
2022-03-24 | American Academy of Dermatology Meeting |
2022-03-24 08:30 am | FY 2021 Earnings Call |
2022-03-24 06:00 am | FY 2021 Earnings Release |
2022-03-11 08:00 am | Investor Meeting - Key Opinion Leader |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBITDA Million USD | Released Forecast Spread | -56,2 -59,6 5.75% | -84,6 -76,6 -10.43% | -89,9 -82,1 -9.44% | -113 -102 -11.48% | -106 -106 -0.4% |
EBIT Million USD | Released Forecast Spread | -58,1 -61,0 4.76% | -86,4 -85,9 -0.53% | -91,9 -89,4 -2.75% | -115 -122 5.28% | -108 -117 7.67% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -56,9 -63,1 9.74% | -85,3 -85,8 0.6% | -93,3 -87,1 -7.03% | -122 -128 4.51% | -114 -120 5.59% |
Net income Million USD | Released Forecast Spread | -60,9 -63,3 3.76% | -85,5 -85,9 0.5% | -93,7 -89,1 -5.1% | -122 -128 4.45% | -115 -121 5.09% |
EPS USD | Released Forecast Spread | -55,6 -59,9 7.13% | -53,4 -51,7 -3.29% | -47,4 -42,2 -12.46% | -46,2 -47,5 2.67% | -26,2 -27,8 5.76% |
Announcement Date | 14/02/19 | 13/02/20 | 09/03/21 | 24/03/22 | 16/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -32,7 -29,2 -11.98% | -27,6 -34,0 18.99% | -28,7 -31,3 8.22% | -29,6 -29,5 -0.42% | -29,1 -30,6 5.19% | -21,1 -30,1 29.96% | -24,9 -21,6 -15.28% | -19,6 -15,7 -25.07% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,6 -29,9 -12.2% | -28,6 -34,3 16.76% | -29,7 -31,6 6.01% | -30,4 -30,0 -1.28% | -30,5 -31,1 2.05% | -23,0 -30,6 24.73% | -25,2 -22,3 -12.82% | -20,9 -16,7 -24.97% |
Net income Million USD | Released Forecast Spread | -33,7 -29,9 -12.72% | -28,7 -34,3 16.48% | -29,9 -31,6 5.65% | -30,6 -30,0 -1.82% | -30,6 -31,1 1.86% | -23,5 -30,6 23.08% | -25,3 -22,3 -13.47% | -21,1 -16,7 -26.37% |
EPS USD | Released Forecast Spread | -12,6 -10,9 -15.95% | -10,8 -12,4 12.9% | -11,2 -12,0 6.35% | -8,00 -8,67 7.69% | -5,60 -6,68 16.17% | -3,40 -5,52 38.41% | -4,60 -3,13 -46.81% | -3,78 -2,99 -26.42% |
Announcement Date | 28/10/21 | 24/03/22 | 12/05/22 | 11/08/22 | 14/11/22 | 16/03/23 | 15/05/23 | 14/08/23 |
Past sector events for Evelo Biosciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EVLO Stock
- Calendar Evelo Biosciences, Inc.